160 related articles for article (PubMed ID: 22816442)
21. Macroporous Hydrogels for Stable Sequestration and Sustained Release of Vascular Endothelial Growth Factor and Basic Fibroblast Growth Factor Using Nucleic Acid Aptamers.
Abune L; Zhao N; Lai J; Peterson B; Szczesny S; Wang Y
ACS Biomater Sci Eng; 2019 May; 5(5):2382-2390. PubMed ID: 31819896
[TBL] [Abstract][Full Text] [Related]
22. Triggered drug release from dynamic microspheres via a protein conformational change.
King WJ; Pytel NJ; Ng K; Murphy WL
Macromol Biosci; 2010 Jun; 10(6):580-4. PubMed ID: 20127670
[TBL] [Abstract][Full Text] [Related]
23. ATP-responsive controlled release system using aptamer-functionalized mesoporous silica nanoparticles.
He X; Zhao Y; He D; Wang K; Xu F; Tang J
Langmuir; 2012 Sep; 28(35):12909-15. PubMed ID: 22889263
[TBL] [Abstract][Full Text] [Related]
24. Characterization of structural changes in aptamer films for controlled release nanodevices.
Serrano-Santos MB; Llobet E; Özalp VC; Schäfer T
Chem Commun (Camb); 2012 Oct; 48(81):10087-9. PubMed ID: 22948231
[TBL] [Abstract][Full Text] [Related]
25. Chimeric Aptamer-Gelatin Hydrogels as an Extracellular Matrix Mimic for Loading Cells and Growth Factors.
Zhang X; Battig MR; Chen N; Gaddes ER; Duncan KL; Wang Y
Biomacromolecules; 2016 Mar; 17(3):778-87. PubMed ID: 26791559
[TBL] [Abstract][Full Text] [Related]
26. Controlled release of IgG by novel UV induced polysaccharide/poly(amino acid) hydrogels.
Tripodo G; Pitarresi G; Cavallaro G; Palumbo FS; Giammona G
Macromol Biosci; 2009 Apr; 9(4):393-401. PubMed ID: 19003848
[TBL] [Abstract][Full Text] [Related]
27. Molecular interaction studies of vascular endothelial growth factor with RNA aptamers.
Zhang X; Yadavalli VK
Analyst; 2010 Aug; 135(8):2014-21. PubMed ID: 20563342
[TBL] [Abstract][Full Text] [Related]
28. Hybridization chain reaction-based aptameric system for the highly selective and sensitive detection of protein.
Song W; Zhu K; Cao Z; Lau C; Lu J
Analyst; 2012 Mar; 137(6):1396-401. PubMed ID: 22318238
[TBL] [Abstract][Full Text] [Related]
29. Endonuclease-responsive aptamer-functionalized hydrogel coating for sequential catch and release of cancer cells.
Li S; Chen N; Zhang Z; Wang Y
Biomaterials; 2013 Jan; 34(2):460-9. PubMed ID: 23083933
[TBL] [Abstract][Full Text] [Related]
30. Highly sensitive antibody-aptamer sensor for vascular endothelial growth factor based on hybridization chain reaction and pH meter/indicator.
Xu H; Kou F; Ye H; Wang Z; Huang S; Liu X; Zhu X; Lin Z; Chen G
Talanta; 2017 Dec; 175():177-182. PubMed ID: 28841975
[TBL] [Abstract][Full Text] [Related]
31. Dynamics of an anti-VEGF DNA aptamer: a single-molecule study.
Nick Taylor J; Darugar Q; Kourentzi K; Willson RC; Landes CF
Biochem Biophys Res Commun; 2008 Aug; 373(2):213-8. PubMed ID: 18555799
[TBL] [Abstract][Full Text] [Related]
32. Aptamer-Functionalized Micro- and Nanocarriers for Controlled Release.
Vázquez-González M; Willner I
ACS Appl Mater Interfaces; 2021 Mar; 13(8):9520-9541. PubMed ID: 33395247
[TBL] [Abstract][Full Text] [Related]
33. Engineered 5S ribosomal RNAs displaying aptamers recognizing vascular endothelial growth factor and malachite green.
Zhang X; Potty AS; Jackson GW; Stepanov V; Tang A; Liu Y; Kourentzi K; Strych U; Fox GE; Willson RC
J Mol Recognit; 2009; 22(2):154-61. PubMed ID: 19195013
[TBL] [Abstract][Full Text] [Related]
34. A nanoscale drug delivery carrier using nucleic acid aptamers for extended release of therapeutic.
Sundaram P; Wower J; Byrne ME
Nanomedicine; 2012 Oct; 8(7):1143-51. PubMed ID: 22321384
[TBL] [Abstract][Full Text] [Related]
35. Heparin-regulated release of growth factors in vitro and angiogenic response in vivo to implanted hyaluronan hydrogels containing VEGF and bFGF.
Pike DB; Cai S; Pomraning KR; Firpo MA; Fisher RJ; Shu XZ; Prestwich GD; Peattie RA
Biomaterials; 2006 Oct; 27(30):5242-51. PubMed ID: 16806456
[TBL] [Abstract][Full Text] [Related]
36. Hybrid polymeric hydrogels for ocular drug delivery: nanoparticulate systems from copolymers of acrylic acid-functionalized chitosan and N-isopropylacrylamide or 2-hydroxyethyl methacrylate.
Barbu E; Verestiuc L; Iancu M; Jatariu A; Lungu A; Tsibouklis J
Nanotechnology; 2009 Jun; 20(22):225108. PubMed ID: 19433871
[TBL] [Abstract][Full Text] [Related]
37. Signaling aptamers created using fluorescent nucleotide analogues.
Katilius E; Katiliene Z; Woodbury NW
Anal Chem; 2006 Sep; 78(18):6484-9. PubMed ID: 16970324
[TBL] [Abstract][Full Text] [Related]
38. Aptamer functionalized DNA hydrogels: Design, applications and kinetics.
Zhao L; Li L; Yang G; Wei B; Ma Y; Qu F
Biosens Bioelectron; 2021 Dec; 194():113597. PubMed ID: 34534951
[TBL] [Abstract][Full Text] [Related]
39. Targeting cancer cells with controlled release nanocapsules based on a single aptamer.
Hernandez FJ; Hernandez LI; Pinto A; Schäfer T; Özalp VC
Chem Commun (Camb); 2013 Feb; 49(13):1285-7. PubMed ID: 23295617
[TBL] [Abstract][Full Text] [Related]
40. DNA-hybrid-gated multifunctional mesoporous silica nanocarriers for dual-targeted and microRNA-responsive controlled drug delivery.
Zhang P; Cheng F; Zhou R; Cao J; Li J; Burda C; Min Q; Zhu JJ
Angew Chem Int Ed Engl; 2014 Feb; 53(9):2371-5. PubMed ID: 24470397
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
